Related Experiment Video
Updated: Aug 30, 2026

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
[Effects of antisense oligodeoxynucleotides of human telomerase reverse transcriptase gene on telomerase activity in
Wen-Yu Li1, Yuan Zhang, Dong-Mei He
1Institute of Hematology, Jinan University Medical College, Guangzhou 510632, China.
Abstract:
To explore the effect of antisense phosphorothioate oligodeoxynucleotide (ASODN) of human telomerase reverse transcriptase (hTERT) gene on telomerase activity in CEM cells, PCR enzyme-linked immunoassay was used to determine telomerase activity. The expression levels of hTERT mRNA and protein were assayed by RT-PCR and immunofluorescence assay using fluoresce isothiocyanate label respectively. The results showed that the expression levels of hTERT mRNA and protein in CEM cells decreased with time after hTERT ASODN treatment. There was no difference in hTERT mRNA and protein levels between control and sense oligodeoxynucleotide-treated cells. Telomerase activity decreased when CEM cells were treated with ASODN for 48 hours. Telomerase activity of CEM cells was significantly inhibited when treated with ASODN for 72 hours. There was no difference in telomerase activity levels between control and hTERT sense oligodeoxynucleotide-treated cells. These results suggested that hTERT ASODN inhibited telomerase activity of CEM cells.
Insights
Antisense phosphorothioate oligodeoxynucleotide targeting the human telomerase reverse transcriptase (hTERT) gene effectively inhibited telomerase activity in CEM cells. This suggests a potential therapeutic strategy for telomerase-dependent conditions.
Area of Science:
- Molecular Biology
- Biochemistry
Context:
- Telomerase plays a crucial role in cell proliferation and is often upregulated in cancer cells.
- Human telomerase reverse transcriptase (hTERT) is the catalytic subunit of telomerase and a key target for therapeutic intervention.
Purpose:
- To investigate the impact of antisense phosphorothioate oligodeoxynucleotide (ASODN) targeting the hTERT gene on telomerase activity and expression in CEM cells.
- To evaluate the specificity of hTERT ASODN by comparing its effects with sense oligodeoxynucleotide treatment.
Summary:
- Treatment of CEM cells with hTERT ASODN led to a time-dependent decrease in hTERT mRNA and protein expression.
- Telomerase activity was significantly inhibited in CEM cells after 48 and 72 hours of hTERT ASODN treatment.
- No significant changes in hTERT expression or telomerase activity were observed in cells treated with sense oligodeoxynucleotide.
Impact:
- These findings demonstrate that hTERT ASODN can effectively suppress telomerase activity in CEM cells.
- This research supports the potential of hTERT ASODN as a therapeutic agent for diseases characterized by elevated telomerase activity, such as cancer.
Related Concept Videos
Telomeres and Telomerase
Replicative Cell Senescence
Replication in Eukaryotes
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
Replication in Eukaryotes

